Myriad Genetics
MYGN
#5187
Rank
A$1.94 B
Marketcap
$21.39
Share price
1.44%
Change (1 day)
-28.91%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.55 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are A$0.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.53 B15.97%
2022-12-31A$0.45 B-5.54%
2021-12-31A$0.48 B
2020-06-30A$0.70 B4.9%
2019-06-30A$0.67 B138.77%
2018-06-30A$0.28 B-50.74%
2017-06-30A$0.57 B223.68%
2016-06-30A$0.17 B30.64%
2015-06-30A$0.13 B21.91%
2014-06-30A$0.11 B35.21%
2013-06-30A$82.3 M53.34%
2012-06-30A$53.67 M30.33%
2011-06-30A$41.18 M-4.46%
2010-06-30A$43.1 M8.03%
2009-06-30A$39.9 M-48.12%
2008-06-30A$76.91 M85.14%
2007-06-30A$41.54 M15.05%
2006-06-30A$36.11 M18.33%
2005-06-30A$30.51 M39.76%
2004-06-30A$21.83 M-24.59%
2003-06-30A$28.95 M-43.01%
2002-06-30A$50.8 M-20.2%
2001-06-30A$63.67 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$4.98 B 791.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.66 B 912.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$34.92 M-93.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.30 B 311.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$54.95 B 9,719.22%๐Ÿ‡บ๐Ÿ‡ธ USA